WinstonWınston
Ethema Health Corporation logo

Ethema Health Corporation

GRST
34
Medical - Care Facilities · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$772,628
Winston Score
34
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+186.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 2.70B (2021) → 7.73B (2025)

Ethema Health Corporation runs addiction treatment centers in the United States and Canada. The company helps people recover from substance abuse, offering residential and outpatient rehabilitation programs. Its main customers are individuals seeking treatment for drug and alcohol dependency, often paid for through insurance or government programs.

Ethema makes money by charging for patient care services, with revenue tied to bed occupancy and treatment program fees. The company is very small, with a near-zero market cap, and operates a limited number of facilities primarily in South Florida and Ontario, Canada. Its high gross margin suggests low direct costs relative to revenue, but the flat operating margin points to heavy overhead expenses eating into profits. The biggest risk the company faces is its extremely small size and thin financial footing, which makes it vulnerable to regulatory changes, reimbursement rate cuts, or any drop in patient volume.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+214.2% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+100.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

54.0%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$114,030 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Revenue accelerating

Ethema Health Corporation grew revenue 214% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
91.4%
Premium pricing power — 91.4% gross margin
Operating Margin
9.9%
Modest — 9.9% operating margin
ROCE
7.3%
Weak — 7.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+171.7%
Fast-growing sales (171.7% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
0/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-5.1%
Burning cash (-5.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
0.00x
Dangerous — barely covers interest (0.0x)

Interest coverage below 1. Their profits don't cover the interest bill.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial